On May 1, 2018 Juniper Pharmaceuticals (Nasdaq:JNP) ("Juniper" or the "Company"), reported that it will hold a conference call on May 10, 2018, to discuss the financial results for the first quarter ended March 31, 2018, as follows (Press release, Juniper Pharmaceuticals, MAY 1, 2018, View Source [SID1234525933]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Date: May 10, 2018
Time: 8:30 a.m. EST
Dial-in numbers: Toll free: (1-866-374-4635) (U.S.), (1-855-669-9657) (Canada), or
International: (1-412-902-4218)
Audio webcast (live & archive): www.juniperpharma.com, under ‘Investors’ or click here.
The teleconference replay will be available approximately one hour after completion through Thursday, March 15, 2018, at 1-877-344-7529 (U.S.), 1-855-669-9658 (Canada) or 1-412-317-0088 (International). The replay access code is 10119657.
The archived webcast will be available for one year via the aforementioned URLs.